These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19134264)

  • 1. [Atypical hemolytic uremic syndrome and the CFH gene].
    Jiang CR; Ye LY; Yu ZH
    Zhonghua Er Ke Za Zhi; 2008 Dec; 46(12):952-5. PubMed ID: 19134264
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical hemolytic uremic syndrome: telling the difference between H and Y.
    Goicoechea de Jorge E; Pickering MC
    Kidney Int; 2010 Oct; 78(8):721-3. PubMed ID: 20877372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome-A pedigree revisited.
    Johnson SA; Williams JM; Hakobyan S; Richards A; Perkins SJ; Marchbank KJ; Goodship TH; Morgan BP; Taylor CM; Savage CO
    Mol Immunol; 2010 Apr; 47(7-8):1585-91. PubMed ID: 20304497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.
    Chaudhary P; Hepgur M; Sarkissian S; Smith RJ; Weitz IC
    Blood Transfus; 2014 Jan; 12(1):111-3. PubMed ID: 24333077
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Fremeaux-Bacchi V; Noris M; Goodship T; Remuzzi G; Atkinson JP
    Clin J Am Soc Nephrol; 2007 May; 2(3):591-6. PubMed ID: 17699467
    [No Abstract]   [Full Text] [Related]  

  • 6. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome.
    Heinen S; Sanchez-Corral P; Jackson MS; Strain L; Goodship JA; Kemp EJ; Skerka C; Jokiranta TS; Meyers K; Wagner E; Robitaille P; Esparza-Gordillo J; Rodriguez de Cordoba S; Zipfel PF; Goodship TH
    Hum Mutat; 2006 Mar; 27(3):292-3. PubMed ID: 16470555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
    Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.
    Ying L; Katz Y; Schlesinger M; Carmi R; Shalev H; Haider N; Beck G; Sheffield VC; Landau D
    Am J Hum Genet; 1999 Dec; 65(6):1538-46. PubMed ID: 10577907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of phenotypes caused by variants in the CFH gene.
    Boon CJ; van de Kar NC; Klevering BJ; Keunen JE; Cremers FP; Klaver CC; Hoyng CB; Daha MR; den Hollander AI
    Mol Immunol; 2009 May; 46(8-9):1573-94. PubMed ID: 19297022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endothelial glycocalyx as a potential modifier of the hemolytic uremic syndrome.
    Boels MG; Lee DH; van den Berg BM; Dane MJ; van der Vlag J; Rabelink TJ
    Eur J Intern Med; 2013 Sep; 24(6):503-9. PubMed ID: 23357408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
    J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes.
    Le Quintrec M; Roumenina L; Noris M; Frémeaux-Bacchi V
    Semin Thromb Hemost; 2010 Sep; 36(6):641-52. PubMed ID: 20865641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Melgosa M; Peña-Carrión A; de Jorge EG; de Córdoba SR; López-Trascasa M; Sánchez-Corral P
    Am J Kidney Dis; 2008 Jul; 52(1):171-80. PubMed ID: 18423815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
    Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
    Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful simultaneous liver-kidney transplant in an adult with atypical hemolytic uremic syndrome associated with a mutation in complement factor H.
    Wilson C; Torpey N; Jaques B; Strain L; Talbot D; Manas D; Goodship T
    Am J Kidney Dis; 2011 Jul; 58(1):109-12. PubMed ID: 21601332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts.
    Fremeaux-Bacchi V; Kemp EJ; Goodship JA; Dragon-Durey MA; Strain L; Loirat C; Deng HW; Goodship TH
    J Med Genet; 2005 Nov; 42(11):852-6. PubMed ID: 15784724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical HUS and complement dysregulation.
    Goodship TH
    J Am Soc Nephrol; 2006 Jul; 17(7):1775-6. PubMed ID: 16790505
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.
    Boyer O; Balzamo E; Charbit M; Biebuyck-Gougé N; Salomon R; Dragon-Durey MA; Frémeaux-Bacchi V; Niaudet P
    Am J Kidney Dis; 2010 May; 55(5):923-7. PubMed ID: 20202729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eculizumab for atypical hemolytic-uremic syndrome.
    Nürnberger J; Philipp T; Witzke O; Opazo Saez A; Vester U; Baba HA; Kribben A; Zimmerhackl LB; Janecke AR; Nagel M; Kirschfink M
    N Engl J Med; 2009 Jan; 360(5):542-4. PubMed ID: 19179328
    [No Abstract]   [Full Text] [Related]  

  • 20. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.
    Buddles MR; Donne RL; Richards A; Goodship J; Goodship TH
    Am J Hum Genet; 2000 May; 66(5):1721-2. PubMed ID: 10762557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.